Notably, the anti‐fibrotic effects of fisetin have been attributed to inhibition of the TGF‐β1 pathway;91, 176 a ubiquitous cytokine well documented as a driver of both senescence and renal fibrosis in the context of hyperglycaemia.94, 95, 180. This evidence concerns the gene TGFB1 and renal fibrosis.